Synopsis
Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cefixime
2. Cefixime Anhydrous
3. Cefixime Trihydrate
4. Fk 027
5. Fk-027
6. Fk027
7. Fr 17027
8. Fr-17027
9. Fr17027
1. Cefixime
2. 97164-56-2
3. 79350-37-1
4. Cefixime(e)-form
5. (e)-cefixime
6. Cefixime Anhydrous, (e)-
7. U7rwt9j78o
8. Cfix
9. (6r,7r)-7-(((2e)-2-(2-amino-4-thiazolyl)-2-((carboxymethoxy)imino)acetyl)amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
10. (6r,7r)-7-[[(2e)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
11. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2e)-2-(2-amino-4-thiazolyl)-2-((carboxymethoxy)imino)acetyl)amino)-3-ethenyl-8-oxo-, (6r,7r)-
12. Cefixime Impurity D
13. Unii-u7rwt9j78o
14. (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
15. Cefiximetrihydrate
16. Prestwick2_000462
17. Epitope Id:116227
18. Schembl24946
19. Schembl49534
20. Chembl427069
21. Bdbm88962
22. Chebi:93248
23. Gtpl10898
24. Cid_56642849
25. Hms1569m06
26. (6r,7r)-7-((z)-2-(2-aminothiazol-4-yl)-2-((carboxymethoxy)imino)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
27. Zinc4468778
28. Ncgc00185001-01
29. (e)-cefixime (cefixime Ep Impurity D)
30. Q163901
31. J-005196
32. J-501698
33. Brd-k04993501-001-01-9
34. [6r-[6alpha,7beta(e)]]-7-[[(2-amino-4-thiazolyl)[(car
35. (6r,7r)-7-[[(2e)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;hydrate
36. (6r,7r)-7-[[(2e)-2-(2-amino-4-thiazolyl)-2-(carboxymethoxyimino)-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;hydrate
37. (6r,7r)-7-[[(2e)-2-(2-aminothiazol-4-yl)-2-(carboxymethyloximino)acetyl]amino]-8-keto-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;hydrate
38. (6r,7r)-7-[[(2e)-2-(2-azanyl-1,3-thiazol-4-yl)-2-(2-hydroxy-2-oxoethyloxyimino)ethanoyl]amino]-3-ethenyl-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;hydrate
39. (6r,7r)-7-[[(2z)-2-(2-amino-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene -2-carboxylic Acid
40. (6r,7r,e)-7-(2-(2-aminothiazol-4-yl)-2-(carboxymethoxyimino)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
| Molecular Weight | 453.5 g/mol |
|---|---|
| Molecular Formula | C16H15N5O7S2 |
| XLogP3 | -0.7 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 8 |
| Exact Mass | 453.04129018 g/mol |
| Monoisotopic Mass | 453.04129018 g/mol |
| Topological Polar Surface Area | 238 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 861 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01D - Other beta-lactam antibacterials
J01DD - Third-generation cephalosporins
J01DD08 - Cefixime
API SUPPLIERS
HRV Pharma - Market Expansion Leader in Pharmaceuticals.
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-11-28
Pay. Date : 2022-08-19
DMF Number : 36694
Submission : 2022-07-22
Status : Active
Type : II
Certificate Number : CEP 2021-361 - Rev 01
Issue Date : 2025-06-19
Type : Chemical
Substance Number : 1188
Status : Valid
Registration Number : 226MF10199
Registrant's Address : No. 849 Dongjia Town, Licheng District, Jinan, Shandong, China
Initial Date of Registration : 2014-10-27
Latest Date of Registration :
Registrant Name : Seongi Bio Co., Ltd.
Registration Date : 2015-05-15
Registration Number : 20150515-26-A-318-10
Manufacturer Name : Qilu Antibiotics Pharmaceutical Co., Ltd
Manufacturer Address : No.849 Dongjia Town, Licheng District, Jinan, Shandong Province, China_x000D_
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-11-27
Pay. Date : 2013-09-19
DMF Number : 27527
Submission : 2013-09-27
Status : Active
Type : II
Certificate Number : R0-CEP 2010-192 - Rev 00
Issue Date : 2014-01-08
Type : Chemical
Substance Number : 1188
Status : Withdrawn by Holder
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41651
Submission : 2025-03-27
Status : Active
Type : II
Certificate Number : CEP 2019-162 - Rev 01
Issue Date : 2024-07-19
Type : Chemical
Substance Number : 1188
Status : Valid
Registration Number : 302MF10060
Registrant's Address : No. 519 Jiangnan Road, Hengdian Industrial Zone, Dongyang City, Jinhua, Zhejiang Province, China
Initial Date of Registration : 2020-05-25
Latest Date of Registration :
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-07-29
Pay. Date : 2014-02-25
DMF Number : 23474
Submission : 2010-01-18
Status : Active
Type : II
Date of Issue : 2022-05-17
Valid Till : 2025-05-16
Written Confirmation Number : WC-0008
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16313
Submission : 2002-12-17
Status : Inactive
Type : II
Certificate Number : R1-CEP 2009-347 - Rev 02
Issue Date : 2018-10-31
Type : Chemical
Substance Number : 1188
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13687
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25390
Submission : 2011-09-30
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9478
Submission : 1991-12-31
Status : Inactive
Type : II
Certificate Number : R1-CEP 2001-073 - Rev 00
Issue Date : 2006-07-13
Type : TSE
Substance Number : 1188
Status : Withdrawn by Holder
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : Complete
Rev. Date : 2014-07-29
Pay. Date : 2014-02-25
DMF Number : 23474
Submission : 2010-01-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9478
Submission : 1991-12-31
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-12-05
Pay. Date : 2013-09-13
DMF Number : 26369
Submission : 2012-09-10
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25390
Submission : 2011-09-30
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15996
Submission : 2002-05-20
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-11-01
Pay. Date : 2012-12-17
DMF Number : 19307
Submission : 2006-03-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17655
Submission : 2004-09-07
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19960
Submission : 2006-11-14
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13687
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16313
Submission : 2002-12-17
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
Certificate Number : R1-CEP 1999-158 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2007-04-04
Type : Chemical
Substance Number : 1188
Certificate Number : R1-CEP 2001-073 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2006-07-13
Type : TSE
Substance Number : 1188
Certificate Number : R1-CEP 2003-014 - Rev 02
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2014-06-02
Type : Chemical
Substance Number : 1188
Certificate Number : R0-CEP 2014-217 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2016-12-02
Type : Chemical
Substance Number : 1188
Certificate Number : R0-CEP 2004-123 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2007-08-01
Type : Chemical
Substance Number : 1188
Certificate Number : R1-CEP 2011-239 - Rev 00
Status : Suspended by EDQM GMP non-compliance
Issue Date : 2019-03-08
Type : Chemical
Substance Number : 1188
Certificate Number : R1-CEP 2001-449 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2008-05-14
Type : Chemical
Substance Number : 1188
Certificate Number : R1-CEP 2009-347 - Rev 02
Status : Valid
Issue Date : 2018-10-31
Type : Chemical
Substance Number : 1188
Certificate Number : R0-CEP 2010-192 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2014-01-08
Type : Chemical
Substance Number : 1188
Certificate Number : R0-CEP 2007-314 - Rev 00
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2010-01-21
Type : Chemical
Substance Number : 1188
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] JDMF
Registration Number : 224MF10092
Registrant's Address : 174, Sirok-ro, Asan-si, Chungcheongnam-do, KOREA
Initial Date of Registration : 2012-04-25
Latest Date of Registration : 2012-04-25
Registration Number : 222MF10120
Registrant's Address : Orchid Towers, 313, Valluvar Kottam High Road, Nungambakkam, Chennai-600 034 India
Initial Date of Registration : 2010-04-02
Latest Date of Registration : 2010-04-02
Registration Number : 226MF10199
Registrant's Address : No. 849 Dongjia Town, Licheng District, Jinan, Shandong, China
Initial Date of Registration : 2014-10-27
Latest Date of Registration : 2023-08-02
Registration Number : 302MF10060
Registrant's Address : No. 519 Jiangnan Road, Hengdian Industrial Zone, Dongyang City, Jinhua, Zhejiang Prov...
Initial Date of Registration : 2020-05-25
Latest Date of Registration : 2020-05-25
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
Regulatory Info :
Registration Country : Italy
Brand Name : CEFIXIMA AUROBINDO ITALY
Dosage Form : Powder For Oral Suspension
Dosage Strength : 100 mg/5 ml
Packaging : 100 ML 2% - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Cefixa
Dosage Form : Cefixima 400Mg 5 Units' Oral Use
Dosage Strength : 5 cpr riv 400 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : CEFIXIME EG
Dosage Form : Powder For Oral Suspension
Dosage Strength : 100 mg/5 ml
Packaging : 100 ML 2% - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : SUPRACEF
Dosage Form : Dispersible Tablets
Dosage Strength : 400 mg
Packaging : 5 UNITS 400 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Cefixoral
Dosage Form : Cefixima 400Mg 5 Units' Oral Use
Dosage Strength : 5 cpr riv 400 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Denvar
Dosage Form : Capsule
Dosage Strength : 400MG
Packaging :
Approval Date : 1994-06-01
Application Number : 60469
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Denvar
Dosage Form : Granule For Oral Suspension
Dosage Strength : 100MG
Packaging :
Approval Date : 1993-02-01
Application Number : 59733
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info :
Registration Country : Italy
Brand Name : Cefixa
Dosage Form : Cefixima 2% 100Ml Oral Use
Dosage Strength : groun os suspe 100 ml 100 mg/5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Stadium
Dosage Form : Cefixima 400Mg 5 Units' Oral Use
Dosage Strength : 5 cpr riv 400 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Cefixa
Dosage Form : Cefixima 400Mg 5 Units' Oral Use
Dosage Strength : 5 cpr dispers 400 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : AURO-CEFIXIME
Dosage Form : TABLET
Dosage Strength : 400MG
Packaging : 7/10/20/500
Approval Date :
Application Number : 2432773
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : AURO-CEFIXIME
Dosage Form : POWDER FOR SUSPENSION
Dosage Strength : 100MG/5ML
Packaging : 50ML/100ML
Approval Date :
Application Number : 2468689
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : SUPRAX
Dosage Form : POWDER FOR SUSPENSION
Dosage Strength : 100MG/5ML
Packaging : 50ML
Approval Date :
Application Number : 868965
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : SUPRAX
Dosage Form : TABLET
Dosage Strength : 400MG
Packaging : 07-Oct
Approval Date :
Application Number : 868981
Regulatory Info : Prescription
Registration Country : Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Exsef
Dosage Form : TAB
Dosage Strength : 400mg
Packaging : 1X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Exsef
Dosage Form : TAB
Dosage Strength : 400mg
Packaging : 5X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Fixime 400 Mg
Dosage Form : TAB
Dosage Strength : 400mg
Packaging : 1X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Fixime 400 Mg
Dosage Form : TAB
Dosage Strength : 400mg
Packaging : 5X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Fixime 400 Mg
Dosage Form : TAB
Dosage Strength : 400mg
Packaging : 10X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
Regulatory Info :
Registration Country : India
Brand Name : Cefixime
Dosage Form : Tablet
Dosage Strength : 400MG
Packaging : 2x6, 1x10
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 2x6, 1x10
Regulatory Info :
Dosage : Tablet
Dosage Strength : 400MG
Brand Name : Cefixime
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Cefixime;Ofloxacin
Dosage Form : Tablet
Dosage Strength : 200MG; 200MG
Packaging : 10x10
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 10x10
Regulatory Info :
Dosage : Tablet
Dosage Strength : 200MG; 200MG
Brand Name : Cefixime;Ofloxacin
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 400MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 400MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Film Coated Tablet
Dosage Strength : 200mg
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Oral Suspension
Dosage Strength : 100mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Oral Suspension
Dosage Strength : 100mg
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Cefixime ; Potassium C...
Dosage Form : Tablet
Dosage Strength : 200 MG ; 125 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 200 MG ; 125 MG
Brand Name : Cefixime ; Potassium C...
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Milfixime-100
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 100MG
Brand Name : Milfixime-100
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : THEOFIX-100 DT
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging : 2x10 Alu-Alu
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 2x10 Alu-Alu
Regulatory Info :
Dosage : Tablet
Dosage Strength : 100MG
Brand Name : THEOFIX-100 DT
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : THEOFIX-200
Dosage Form : Tablet
Dosage Strength : 200MG
Packaging : 2x10 Alu-Alu & 10 x 10 Alu-Alu
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 2x10 Alu-Alu & 10 x 10 Alu-Alu
Regulatory Info :
Dosage : Tablet
Dosage Strength : 200MG
Brand Name : THEOFIX-200
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Cefixime; Clavulanate Potassium
Brand Name : CefiClav 325\n
Dosage Form : Tablet
Dosage Strength : 200MG; 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Packaging :
Regulatory Info :
Cefixime; Clavulanate Potassium
Dosage : Tablet
Dosage Strength : 200MG; 125MG
Brand Name : CefiClav 325\n
Approval Date :
Application Number :
Registration Country : India
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - FOR SUSPENSION;ORAL - 500MG/5ML
USFDA APPLICATION NUMBER - 202091
DOSAGE - CAPSULE;ORAL - 400MG
USFDA APPLICATION NUMBER - 203195
Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Bioplus Life Sciences
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CD Formulation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Esteem Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Keval Exports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Coating Systems & Additives
Thickeners and Stabilizers
Direct Compression
Taste Masking
Granulation
Controlled & Modified Release
Chewable & Orodispersible Aids
Topical
Disintegrants & Superdisintegrants
Lubricants & Glidants
Co-Processed Excipients
Film Formers & Plasticizers
Empty Capsules
Solubilizers
Rheology Modifiers
Parenteral
Emulsifying Agents
API Stability Enhancers
Coloring Agents
Vegetarian Capsules
Surfactant & Foaming Agents
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
13 Aug 2025
Reply
30 Jul 2025
Reply
23 Apr 2025
Reply
01 Apr 2025
Reply
02 Jan 2025
Reply
19 Nov 2024
Reply
18 Sep 2024
Reply
19 Feb 2024
Reply
22 Nov 2023
Reply
05 Oct 2023
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
61
PharmaCompass offers a list of Cefixime API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cefixime manufacturer or Cefixime supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefixime manufacturer or Cefixime supplier.
PharmaCompass also assists you with knowing the Cefixime API Price utilized in the formulation of products. Cefixime API Price is not always fixed or binding as the Cefixime Price is obtained through a variety of data sources. The Cefixime Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cefixime Anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefixime Anhydrous, including repackagers and relabelers. The FDA regulates Cefixime Anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefixime Anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cefixime Anhydrous manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cefixime Anhydrous supplier is an individual or a company that provides Cefixime Anhydrous active pharmaceutical ingredient (API) or Cefixime Anhydrous finished formulations upon request. The Cefixime Anhydrous suppliers may include Cefixime Anhydrous API manufacturers, exporters, distributors and traders.
click here to find a list of Cefixime Anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cefixime Anhydrous DMF (Drug Master File) is a document detailing the whole manufacturing process of Cefixime Anhydrous active pharmaceutical ingredient (API) in detail. Different forms of Cefixime Anhydrous DMFs exist exist since differing nations have different regulations, such as Cefixime Anhydrous USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cefixime Anhydrous DMF submitted to regulatory agencies in the US is known as a USDMF. Cefixime Anhydrous USDMF includes data on Cefixime Anhydrous's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cefixime Anhydrous USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cefixime Anhydrous suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cefixime Anhydrous Drug Master File in Japan (Cefixime Anhydrous JDMF) empowers Cefixime Anhydrous API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cefixime Anhydrous JDMF during the approval evaluation for pharmaceutical products. At the time of Cefixime Anhydrous JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cefixime Anhydrous suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cefixime Anhydrous Drug Master File in Korea (Cefixime Anhydrous KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cefixime Anhydrous. The MFDS reviews the Cefixime Anhydrous KDMF as part of the drug registration process and uses the information provided in the Cefixime Anhydrous KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cefixime Anhydrous KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cefixime Anhydrous API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cefixime Anhydrous suppliers with KDMF on PharmaCompass.
A Cefixime Anhydrous CEP of the European Pharmacopoeia monograph is often referred to as a Cefixime Anhydrous Certificate of Suitability (COS). The purpose of a Cefixime Anhydrous CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cefixime Anhydrous EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cefixime Anhydrous to their clients by showing that a Cefixime Anhydrous CEP has been issued for it. The manufacturer submits a Cefixime Anhydrous CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cefixime Anhydrous CEP holder for the record. Additionally, the data presented in the Cefixime Anhydrous CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cefixime Anhydrous DMF.
A Cefixime Anhydrous CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cefixime Anhydrous CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cefixime Anhydrous suppliers with CEP (COS) on PharmaCompass.
A Cefixime Anhydrous written confirmation (Cefixime Anhydrous WC) is an official document issued by a regulatory agency to a Cefixime Anhydrous manufacturer, verifying that the manufacturing facility of a Cefixime Anhydrous active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cefixime Anhydrous APIs or Cefixime Anhydrous finished pharmaceutical products to another nation, regulatory agencies frequently require a Cefixime Anhydrous WC (written confirmation) as part of the regulatory process.
click here to find a list of Cefixime Anhydrous suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cefixime Anhydrous as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cefixime Anhydrous API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cefixime Anhydrous as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cefixime Anhydrous and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cefixime Anhydrous NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cefixime Anhydrous suppliers with NDC on PharmaCompass.
Cefixime Anhydrous Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cefixime Anhydrous GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cefixime Anhydrous GMP manufacturer or Cefixime Anhydrous GMP API supplier for your needs.
A Cefixime Anhydrous CoA (Certificate of Analysis) is a formal document that attests to Cefixime Anhydrous's compliance with Cefixime Anhydrous specifications and serves as a tool for batch-level quality control.
Cefixime Anhydrous CoA mostly includes findings from lab analyses of a specific batch. For each Cefixime Anhydrous CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cefixime Anhydrous may be tested according to a variety of international standards, such as European Pharmacopoeia (Cefixime Anhydrous EP), Cefixime Anhydrous JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cefixime Anhydrous USP).
Comment (5)
